A recent study has demonstrated the potential of a metabolism-targeting drug in alleviating cancer-related fatigue (CRF) without interfering with cancer treatments.
CRF is a debilitating condition that significantly impacts the quality of life for cancer patients undergoing treatment.
Until now, there have been no effective pharmaceutical treatments for this syndrome, which encompasses various symptoms.
Key Findings
Researchers explored the use of dichloroacetate (DCA), an activator of glucose oxidation, in treating CRF in mouse models with melanoma.
Importantly, the study revealed that DCA did not impact tumor growth rates or compromise the efficacy of immunotherapy or chemotherapy in these mouse models.
Instead, DCA significantly preserved physical function and motivation, particularly in mice with late-stage tumors.
Positive Effects of DCA
The study findings suggest that DCA treatment has several potential benefits, including a reduction in oxidative stress within the muscle tissue of tumor-bearing mice.
Researchers believe that DCA could be used as an adjunct therapy to address CRF in the future.
Implications and Future Research
The study’s results pave the way for future research into treatments for cancer-related fatigue and may eventually lead to novel therapies for patients.
The researchers hope that their work will serve as a foundation for future clinical trials involving DCA, which is already an FDA-approved drug for a different condition (lactic acidosis).
This research was funded by a Young Investigator Award from the Melanoma Research Alliance.
Conclusion
Cancer-related fatigue is a significant challenge for cancer patients undergoing treatment. The study’s identification of DCA as a potential intervention for CRF, without compromising cancer treatments, is promising.
This research offers hope for improved quality of life and symptom management for cancer patients and opens doors for further investigations into this innovative approach to treating CRF.
If you care about health, please read studies about how the Mediterranean diet could protect your brain health, and the best time to take vitamins to prevent heart disease.
For more information about health, please see recent studies that olive oil may help you live longer, and vitamin D could help lower the risk of autoimmune diseases.
The research findings can be found in the American Journal of Physiology-Endocrinology and Metabolism.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
